Dr. Kiran Motaparthi, MD

Dr. Motaparthi practices at UF Health Shands Hospital in Gainesville, Florida, part of UF Health.

Dr. Motaparthi's NPI, 1205081577, was assigned on November 29, 2008. Dr. Motaparthi graduated from Baylor College Of Medicine in 2007. Dr. Motaparthi holds Florida license ME121387.

Dr. Motaparthi's primary practice is UF Health Shands Hospital, at 1600 SW Archer Rd, Gainesville, FL 32610 in Alachua County. The practice phone is (352) 265-8000.

Dr. Motaparthi's primary practice is UF Health Shands Hospital in Gainesville, Florida, part of UF Health. The medical group on file is UF Health Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Motaparthi practices. Vendor and product names are available with a free account.

Dermatology is Dr. Motaparthi's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Motaparthi is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Motaparthi's licenses on file in 15 states: Florida, California, New Mexico, New York, Texas, Colorado, Indiana, Kentucky, Louisiana, Massachusetts, Minnesota, Missouri, New Jersey, Nevada and Pennsylvania.

Dmand AI lists acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, hives, itchy rashes, psoriasis and rash among the conditions Dr. Motaparthi treats.

CMS data shows 707 Medicare services from Dr. Motaparthi across 15 procedure codes in 2024, for 333 Medicare patients. Medicare paid $33,344 for them.

CMS counts 333 Medicare patients who saw Dr. Motaparthi in 2024. The largest group is 65 to 74, with 135 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Motaparthi's median patient age at 76, with 47% women.

In 2024, Dr. Motaparthi wrote 395 Medicare Part D claims for 147 patients. 80% of them were for generic drugs. CMS names the drug for 228 of them, across 11 drugs with 11 or more claims each, at $341,415 in total drug cost. In 2023, CMS named 129 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 48 out of 100 for Dr. Motaparthi for performance year 2024, reported through an alternative payment model (APM). Dr. Motaparthi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Motaparthi as offering telehealth. CMS counts 89 procedures of skin biopsy by Dr. Motaparthi, more than 74% of the clinicians it reports for that procedure.

Dmand AI links 228 papers to Dr. Motaparthi, published from 2011 to 2025. 2021 was the busiest year, with 29. The most frequent topics are Skin Neoplasms, Dermatology and Diagnosis, Differential. Dr. Motaparthi has published most often in JAAD Case Rep. Dr. Motaparthi's most frequent co-authors are Sylvia Hsu, MD, Jennifer J. Schoch, MD and Colton B. Nielson, MD.

CMS Open Payments shows 4 general payments to Dr. Motaparthi from 3 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Amgen Inc. paid the most, $125.

Dmand AI lists 13 awards for Dr. Motaparthi, most recently Exemplary Teacher Award in 2018.

Dr. Motaparthi graduated from Baylor College Of Medicine in 2007.

Dr. Motaparthi is in network with 16 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.